Repligen Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Repligen's inventory turnover ratio sequentially decreased to 2.08 in the second quarter 2026, otherwise the ratio remained above the average, as RGEN's markets remain strong.Repligen's average inventory processing period in the Jun 30 2026 quarter, has increased to 175 days, from 169 days, in the Mar 31 2026 quarter.

Within Healthcare sector 192 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1042 in the first quarter 2026, to 1491.

RGEN Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Repligen Corp Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RGEN Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	19.72 %	17.08 %	19.23 %	-12.14 %	-18.19 %
Y / Y Cost of Sales Growth	3.14 %	9.64 %	-26.9 %	14.09 %	17.99 %
Inventory Turnover Ratio (TTM)	2.08	2.16	2.2	2.53	2.37
RGEN's Total Ranking	# 1491	# 1042	# 1042	# 853	# 849
Average inventory processing period	175	169	166	144	154
Seq. Inventory Growth	4.1 %	5.16 %	6.32 %	2.86 %	1.8 %
Seq. Cost of Sales Growth	9.45 %	-8.62 %	6.56 %	-3.22 %	16.33 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 17
Healthcare Sector	# 193
Overall Market	# 1491

Inventory Turnover Ratio Statistics
High	Average	Low
2.54	2.01	1.37
(Mar 31 2013)		(Jun 30 2012)

RGEN Company Profile >> Back to RGEN Efficiency Comparisons >> Compare RGEN Inventory Turnover Ratio to its Competitors

Financial Statements
Repligen's Inventories	$ 187 Millions	Visit RGEN's Balance sheet
Repligen's Cost of Revenues TTM	$ 362 Millions	Visit RGEN's Income Statement
What are RGEN's Sales?		Visit RGEN's Sales by Segment

Other Inventory Turnover Ratios
Repligen's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
RGEN's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for RGEN's Competitors
Inventory Turnover Ratio for RGEN's Suppliers
Inventory Turnover Ratio for RGEN's Customers

You may also want to know
RGEN's Sales Growth Rates	RGEN's Pe Price to earnings ratio	RGEN's Receivables Turnover Ratio	RGEN's Stock Quote
RGEN's Net Income Growth Rates	RGEN's Ps Price to Sales ratio	RGEN's Sales per Employee	RGEN's Asset Turnover Ratio
RGEN's Net Margin	RGEN's Pb Price to Book ratio	RGEN's Financial Strength Ratios	RGEN's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Tactile Systems Technology Inc	5.12	$ 81.349 Millions	$ 16 Millions
Integer Holdings Corporation	5.03	$ 1,369.168 Millions	$ 272 Millions
Harrow Inc	4.93	$ 73.636 Millions	$ 15 Millions
Ufp Technologies Inc	4.93	$ 452.046 Millions	$ 92 Millions
Veracyte Inc	4.84	$ 102.741 Millions	$ 21 Millions
West Pharmaceutical Services Inc	4.72	$ 2,103.100 Millions	$ 445 Millions
Henry Schein Inc	4.68	$ 9,342.000 Millions	$ 1,997 Millions
Guardant Health Inc	4.53	$ 413.947 Millions	$ 91 Millions
Idexx Laboratories Inc	4.44	$ 1,714.440 Millions	$ 386 Millions
Cryoport inc	4.40	$ 98.679 Millions	$ 22 Millions
Adc Therapeutics Sa	4.17	$ 5.806 Millions	$ 1 Millions
Scilex Holding Company	4.08	$ 14.867 Millions	$ 4 Millions
Medinotec Inc	4.08	$ 4.736 Millions	$ 1 Millions
Alpha Teknova Inc	4.08	$ 28.288 Millions	$ 7 Millions
3m Company	4.07	$ 15,258.000 Millions	$ 3,754 Millions
Electromed Inc	4.02	$ 14.133 Millions	$ 4 Millions
Novocure Limited	4.02	$ 166.921 Millions	$ 41 Millions
Elite Pharmaceuticals Inc	3.95	$ 78.824 Millions	$ 20 Millions
Lftd Partners Inc	3.89	$ 29.233 Millions	$ 8 Millions
Pmgc Holdings Inc	3.87	$ 1.364 Millions	$ 0 Millions
Sonoma Pharmaceuticals Inc	3.83	$ 13.392 Millions	$ 3 Millions
Intelligent Bio Solutions Inc	3.80	$ 2.165 Millions	$ 1 Millions
Iridex Corp	3.80	$ 32.517 Millions	$ 9 Millions
Teva Pharmaceutical Industries Limited	3.66	$ 8,232.000 Millions	$ 2,250 Millions
Neuraxis Inc	3.55	$ 0.783 Millions	$ 0 Millions
Beyond Air Inc	3.51	$ 6.447 Millions	$ 2 Millions
Nexgel Inc	3.49	$ 7.577 Millions	$ 2 Millions
Lifeward ltd	3.47	$ 13.976 Millions	$ 4 Millions
Bellevue Life Sciences Acquisition Corp	3.38	$ 1.215 Millions	$ 0 Millions
10x Genomics Inc	3.29	$ 184.539 Millions	$ 56 Millions

Date modified: 2026-08-12T20:46:18+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.